Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma

BACKGROUND: Non-germinal center B-cell-like diffuse large B-cell lymphoma (non-GCB-DLBCL) has worse clinical outcome than GCB-DLBCL, and some relapsed/refractory non-GCB-DLBCL (R/R non-GCB-DLBCL) are even resistant to CD20 monoclonal antibody (rituximab). Bruton’s tyrosine kinase inhibitors (BTKis)...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xin, Wei, Ting, Zhong, Weijie, Ang, Rosalind, Lei, Ye, Zhang, Hui, Li, Qingshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025353/
https://www.ncbi.nlm.nih.gov/pubmed/33827598
http://dx.doi.org/10.1186/s12935-021-01891-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025353/
https://www.ncbi.nlm.nih.gov/pubmed/33827598
http://dx.doi.org/10.1186/s12935-021-01891-2

Ejemplares similares